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Language, Jargon, Culture, and Understanding… 
 
It would be difficult to find anyone in the world has been affected by COVID-19 over the past 
year. Essentially everyone has found themselves isolated from their usual lives; concerned for 
their health and mortality; worried for the well-being of family, friends, and neighbors; and 
trying desperately to find a word of hope that everything will be alright, in the end. 
 
With all of the huge changes in our culture in response to the SARS-CoV-2 virus, perhaps one of 
the most interesting shifts is that clinical, medical, and scientific research has assumed a new 
interest from citizens everywhere, up front and in the spotlight. Politicians, news media, and 
private citizens recite the mantra, “we must follow the science” when planning strategies to cope 
and prevail. Yet, as a scientist, I wonder how easy is it for those not familiar with our research to 
be able to follow the science? 
 
This question has nothing to do with intelligence, education, or common-sense, per se. Rather, 
clinical, medical, and scientific research has a technical language, jargon, and culture of thought 
and interpretation that we, in these fields, use to view the world, comprehend what we see, and 
communicate out understandings to each other. Technical jargon and culture not only brings a 
community together through commonality of interest, but also tend to exclude others because of 
the esoteric nature of the un-commonality. 
 
Let me give you an example. I have personally never been quite able to understand the 
intricacies of accounting. My accountant friends have tried to explain the rationale of basic 
accounting to me. It isn’t long before they usually resort to speaking to me as if I were a 
kindergarten student, not out of condescension, but rather because I still cannot understand why 
debits are positive and credits are negative. It makes sense and works perfectly for accountants, 
obviously, but my simple biochemist brain cannot grasp the underlying logic structure that seems 
backward.  
 
In the fact of the confusion, fear, and high stakes of COVID-19, so many people who are not 
schooled in clinical research have been watching the news every day, reading literature published 
in Google Scholar, and desiring to find the latest research findings that make sense of the 
pandemic. Such understanding is critical to their lives, their emotional well-beings, and their 
futures. However, research is not a day-to-day event. Valid research takes a good deal of time to 
plan, usually weeks if we are rushing. Then preparing for a study, gathering the materials 
(especially during COVID shortages of everything), training personnel, nailing down logistics 
and tactics, getting IRB approvals, lining up clinical sites, getting healthcare personnel trained 
and getting research materials out to them, finding subjects, settling funding, and on and on. And 
since research builds on previous research, the foundational work of a field has to be first be 
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performed, peer-reviewed, and then published. So, to expect reliable research on the etiology, 
mechanism, treatment, and follow-up of COVID-19 within months of its discovery is 
unreasonable. Researchers are aware of that. Healthcare providers know reasonable time courses. 
People outside of the research community cannot be expected to know the length of time 
necessary to produce solid, reviewed, and validated interpretations of the data from such 
research, and then to disseminate those interpretations into the zeitgeist of a research problem. 
 
To make matters worse, even people within the healthcare community have been confused 
because of conflicting reports from the many un-reviewed pre-prints of work that have flooded 
the internet. Researchers are skeptical of submitted manuscripts until they have been vetted 
through the peer-review system, and even then researchers are still critical when reading results. 
We cannot expect non-researchers to know the process, or critically assess the published results. 
When people don’t know what they don’t know, they make unintentional mistakes. And that 
leads to a good bit of the confusion that we see around us in society today.  
 
The confusion by all of the conflicting, often politically-driven, publications, research, and 
editorial commentary on COVID-19 lead people to cherry-pick the research reports that make 
sense to them, and are consistent with their own beliefs about the situation. This is not a new 
phenomenon, of course, because we have seen this sort of cherry-picking with topics such as 
vaccine safety, climate change, and whether human beings have ever actually landed on the 
moon. But with COVID, the number of conspiracy theories, distrust of government or big 
business, and denial that an actual crisis even exists seems to be disproportional to usual societal 
concerns. We see this reflected in the considerable number of Americans who refuse to receive 
COVID-19 vaccines because of unsupportable political or personal beliefs.  
 
Our current cultural situation makes it clear that calls to “follow the science” are easily spoken, 
yet difficult to put into action. Scientists, clinicians, and researchers NEVER agree on 
everything. Data is not interpreted the same by every researcher who looks at it. That is the 
strength of research, because it leads to interactional and continuing discussion about research 
problems within our research community. In my field, there are many basic questions that 
respected researchers vary broadly in their interpretation of how to explain those questions. But 
that is a reflection of a healthy research arena. Still, how do individuals outside of the field 
interpret the heterogeneity of points-of-view?  
 
Now is a good time for the research community to seize this opportunity to improve the means 
by which we communicate clearly, counsel wisely, and lead effectively, in matters that fall 
within our expertise.  
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